EUVIMED · CrossrefJournal
The Innovation Medicine
ISSN 2959-8745 · Innovation Press Co., Limited
Latest articles
The value of mucosal immunization against bacterial infections: will we conquer tuberculosis in the near future?
C5aR inhibitors: New dawn and challenges from pathophysiological mechanisms to clinical treatment
Urban One Health: Advancing health and well-being nexus across humans, animals, and urban ecosystems
Innate immune restoration after major surgery in the elderly: functional adaptation for maintaining immune reactivity
Artificial intelligence- and pediatric CBCT-aided developmental recognition and personalized treatment of periapical diseases
Chimeric Antigen Receptor T-cell therapy in pediatric refractory systemic lupus erythematosus
Artificial intelligence for medicine 2025: Navigating the endless frontier
Non-invasive neuromodulation assisted by exogenous stimuli-responsive nanoplatforms for Alzheimer’s disease and Parkinson's disease therapy
Dendritic cells instruct T cell anti-tumor immunity and immunotherapy response
First-in-human study of high-dose gp96 in ALS: Safety and preliminary immunological effects
Efficacy of temporal interference electrical stimulation for spinal cord injury rehabilitation
Current landscape with an analytical outlook: Chikungunya virus vaccine development
CRISPRa engineered Elite macrophages enable adoptive cell therapy for rheumatoid arthritis
Quizartinib is a good option for AML patients with FLT3-ITD mutations
DNA replication stress stratifies prognosis and enables exploitable therapeutic vulnerabilities of HBV-associated hepatocellular carcinoma: An in-silico precision oncology strategy
Association between air pollution and telomere length: A study of 471,808 UK Biobank participants
Universal chimeric antigen receptor-T cells: An opening era for T-cell malignancies
The Innovation Medicine: An international journal of medical science
Win-win cooperation for advancing medical innovation
Highlights from AACR 2023 Annual Meeting
COVID-19 Pandemic: End of emergency, but not end of challenge
Pushing the boundary of cancer diagnostics through microfluidic technologies
Lilly's Donanemab, will it be the light at the end of the tunnel?
Gantt chart for updated OS and PFS after cancer targeted therapy
Basiliximab is the potential solution for severe liver chronic GVHD: A prospective pilot study
Can androgens be replaced by AMH in initial screening of Polycystic Ovary Syndrome?
High self-healing rate of oral ranula: A prospective study
Bioinformatics: Advancing biomedical discovery and innovation in the era of big data and artificial intelligence
Young adults' blood selenium and lung function in Shandong Province, China: A prospective cohort study
Immune cell membrane-coated nanoparticles for targeted myocardial ischemia/reperfusion injury therapy
EUVIMED